MARCIA NORWICH: Open Payments
NPI 1699081653 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 57 payments from 20 companies in 2025. Trend: 2023 $1,718 · 2024 $1,100 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $332 |
| AstraZeneca Pharmaceuticals LP | 4 | $139 |
| Lilly USA, LLC | 6 | $111 |
| Novo Nordisk Inc | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| PFIZER INC. | 2 | $41 |
| Lundbeck LLC | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
Products named: VRAYLAR, AIRSUPRA, UBRELVY, MOUNJARO, REXULTI, QULIPTA, CAPLYTA, ZORYVE.
Industry payments across KS — which companies pay providers there.
